Elisabeth Rutledge, PhD, is a Business Development Manager at Amgen since March 2022, bringing a strong background in life sciences and technology transfer. Prior experience includes roles as a Life Sciences Licensing Associate and Technology Transfer Intern at the USC Stevens Center for Innovation from May 2019 to March 2022, and as a Research Associate at City of Hope, where genomic analysis was conducted on cancer patients to enhance diagnostic probes. Elisabeth holds an MBA from the USC Marshall School of Business, expected in May 2024, a PhD in Development, Stem Cell, and Regenerative Medicine from the University of Southern California, attained in 2019, and a Bachelor of Arts in Cell and Molecular Biology from Occidental College, completed in 2010.
This person is not in any teams
This person is not in any offices